TY - JOUR
T1 - Femoral nerve palsy in brace treatment for developmental dysplasia of the hip
T2 - incidence and outcomes in a prospective international cohort
AU - Global Hip Dysplasia Study Group
AU - Schaeffer, Emily
AU - Wang, Alice Wei Ting
AU - Hu, Jack
AU - Nguyen, Vuong
AU - Sankar, Wudbhav
AU - Williams, Nicole
AU - Mulpuri, Kishore
AU - Aarvold, Alexander
AU - Aroojis, Alaric
AU - Bade, David
AU - Bavan, Luckshman
AU - Benaroch, Thierry
AU - Castañeda, Pablo
AU - Clarke, Nicholas
AU - Dodwell, Emily
AU - Donnan, Leo
AU - Dulai, Sukhdeep
AU - Gardner, Richard
AU - Grigoriou, Emmanouil
AU - Herrera-Soto, Jose
AU - Hopper, Nikki
AU - Jaremko, Jacob
AU - Kelley, Simon
AU - Kim, Harry
AU - Krishnamoorthy, Venkatadass
AU - Matheney, Travis
AU - Mulpuri, Kishore
AU - Patwardhan, Sandeep
AU - Price, Charles
AU - Pun, Stephanie
AU - Reidy, Mike
AU - Sahu, Chittaranjan
AU - Sankar, Wudbhav
AU - Schaeffer, Emily
AU - Shah, Hitesh
AU - Smit, Kevin
AU - Thacker, Mihir
AU - Upasani, Salil
AU - Williams, Nicole
AU - Yihua, Ge
AU - Zhang, Zhongli
N1 - © 2026 Schaeffer et al.
PY - 2026/6/1
Y1 - 2026/6/1
N2 - Aims: Femoral nerve palsy is a potential complication of brace treatment for children with developmental dysplasia of the hip (DDH). Little is known about its causes, and previous studies have been limited by their small sample size, retrospective design, and/or being single-centre series. The aim of this study was to examine the risk factors for femoral nerve palsy in the largest prospective cohort of children to date with DDH treated using an orthosis. Methods: A global multicentre prospective database of children with DDH was analyzed. Those treated primarily using an orthosis were included. Mixed-effects logistic regression was used to identify risk factors for the development of femoral nerve palsy, including sex, age at the time of diagnosis and application of an orthosis, the type of orthosis, the location of the femoral head, femoral head cover, and α angle. Both univariate and multivariate analyses were conducted. Results: The study included 3,008 children (5,012 affected hips) who were enrolled from 21 centres in seven countries; 99 hips (2.0%) in 94 children (3.1%) developed a femoral nerve palsy, which occurred at a median of seven days (IQR 6 to 21) after the application of a brace. A significantly increased proportion of children who developed a femoral nerve palsy were treated in a Pavlik harness compared with those who did not develop a femoral nerve palsy (84.0% (n = 79) vs 61.9% (n = 1,804); p < 0.001). Univariate analyses identified a lower percent cover of the femoral head (odds ratio (OR) 0.87 (95% CI 0.84 to 0.91); p < 0.001) and lower α angle (OR 0.82 (95% CI 0.76 to 0.89); p < 0.001) to be significantly associated with the development of femoral nerve palsy. These risk factors remained significant in the multivariate model. Conclusion: This is the largest multinational study to date evaluating the incidence and risk factors for the development of a femoral nerve palsy in these children. The incidence of femoral nerve palsy was 3.1%. The severity of DDH was identified as a significant risk factor for its development. The use of a Pavlik harness was significantly associated with the development of a femoral nerve palsy. Understanding the factors which influence its development will be important to optimize outcomes of treatment in children with DDH.
AB - Aims: Femoral nerve palsy is a potential complication of brace treatment for children with developmental dysplasia of the hip (DDH). Little is known about its causes, and previous studies have been limited by their small sample size, retrospective design, and/or being single-centre series. The aim of this study was to examine the risk factors for femoral nerve palsy in the largest prospective cohort of children to date with DDH treated using an orthosis. Methods: A global multicentre prospective database of children with DDH was analyzed. Those treated primarily using an orthosis were included. Mixed-effects logistic regression was used to identify risk factors for the development of femoral nerve palsy, including sex, age at the time of diagnosis and application of an orthosis, the type of orthosis, the location of the femoral head, femoral head cover, and α angle. Both univariate and multivariate analyses were conducted. Results: The study included 3,008 children (5,012 affected hips) who were enrolled from 21 centres in seven countries; 99 hips (2.0%) in 94 children (3.1%) developed a femoral nerve palsy, which occurred at a median of seven days (IQR 6 to 21) after the application of a brace. A significantly increased proportion of children who developed a femoral nerve palsy were treated in a Pavlik harness compared with those who did not develop a femoral nerve palsy (84.0% (n = 79) vs 61.9% (n = 1,804); p < 0.001). Univariate analyses identified a lower percent cover of the femoral head (odds ratio (OR) 0.87 (95% CI 0.84 to 0.91); p < 0.001) and lower α angle (OR 0.82 (95% CI 0.76 to 0.89); p < 0.001) to be significantly associated with the development of femoral nerve palsy. These risk factors remained significant in the multivariate model. Conclusion: This is the largest multinational study to date evaluating the incidence and risk factors for the development of a femoral nerve palsy in these children. The incidence of femoral nerve palsy was 3.1%. The severity of DDH was identified as a significant risk factor for its development. The use of a Pavlik harness was significantly associated with the development of a femoral nerve palsy. Understanding the factors which influence its development will be important to optimize outcomes of treatment in children with DDH.
KW - Humans
KW - Braces/adverse effects
KW - Female
KW - Male
KW - Prospective Studies
KW - Femoral Neuropathy/etiology
KW - Incidence
KW - Risk Factors
KW - Infant
KW - Child, Preschool
KW - Developmental Dysplasia of the Hip/therapy
KW - Treatment Outcome
KW - Child
UR - https://www.scopus.com/pages/publications/105040842617
U2 - 10.1302/0301-620X.108B6.BJJ-2025-1550.R1
DO - 10.1302/0301-620X.108B6.BJJ-2025-1550.R1
M3 - Article
C2 - 42219184
AN - SCOPUS:105040842617
SN - 2049-4394
VL - 108-B
SP - 840
EP - 846
JO - The bone & joint journal
JF - The bone & joint journal
IS - 6
ER -